Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Individualized Non-invasive Brain Stimulation for the Treatment of Major Depressive Disorder

NCT: NCT06874374 · COMPLETED

NCT IDNCT06874374
StatusCOMPLETED
Start Date2025-04-11
Completion2026-05-22
SponsorPulvinar Neuro, LLC (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this research study is to study a closed-loop transcranial alternating current stimulation (tACS) device to evaluate feasibility of the product in a clinical trial and collect preliminary data on potential effects on symptoms of depression in people with major depressive disorder.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑